97 related articles for article (PubMed ID: 12957254)
1. Nonrandomized comparison between definitive chemoradiotherapy and radical surgery in patients with T(2-3)N(any) M(0) squamous cell carcinoma of the esophagus.
Hironaka S; Ohtsu A; Boku N; Muto M; Nagashima F; Saito H; Yoshida S; Nishimura M; Haruno M; Ishikura S; Ogino T; Yamamoto S; Ochiai A
Int J Radiat Oncol Biol Phys; 2003 Oct; 57(2):425-33. PubMed ID: 12957254
[TBL] [Abstract][Full Text] [Related]
2. Predictive factors of survival in patients treated with definitive chemoradiotherapy for squamous cell esophageal carcinoma.
Di Fiore F; Lecleire S; Rigal O; Galais MP; Ben Soussan E; David I; Paillot B; Jacob JH; Michel P
World J Gastroenterol; 2006 Jul; 12(26):4185-90. PubMed ID: 16830371
[TBL] [Abstract][Full Text] [Related]
3. Esophageal stenosis and the Glasgow Prognostic Score as independent factors of poor prognosis for patients with locally advanced unresectable esophageal cancer treated with chemoradiotherapy (exploratory analysis of JCOG0303).
Okuno T; Wakabayashi M; Kato K; Shinoda M; Katayama H; Igaki H; Tsubosa Y; Kojima T; Okabe H; Kimura Y; Kawano T; Kosugi S; Toh Y; Kato H; Nakamura K; Fukuda H; Ishikura S; Ando N; Kitagawa Y;
Int J Clin Oncol; 2017 Dec; 22(6):1042-1049. PubMed ID: 28717855
[TBL] [Abstract][Full Text] [Related]
4. Definitive radiation therapy for inoperable stage III/IV cutaneous squamous cell carcinoma: A single-institution retrospective cohort study.
Granger EE; Kim EY; Karn EE; Groover MK; Silk AW; Margalit DN; Tishler RB; Schoenfeld JD; Ruiz ES
J Am Acad Dermatol; 2024 Jan; 90(1):187-189. PubMed ID: 37734666
[No Abstract] [Full Text] [Related]
5. Improving Outcomes with Chemoradiotherapy in the Mucosal Squamous Cell Carcinomas - Immune Checkpoint Inhibition and Broken Promises.
Samuel R; Samson A; Gilbert DC
Clin Oncol (R Coll Radiol); 2023 Dec; 35(12):764-768. PubMed ID: 37743210
[No Abstract] [Full Text] [Related]
6. Phase II study of chemoradiotherapy with 5-fluorouracil and cisplatin for Stage II-III esophageal squamous cell carcinoma: JCOG trial (JCOG 9906).
Kato K; Muro K; Minashi K; Ohtsu A; Ishikura S; Boku N; Takiuchi H; Komatsu Y; Miyata Y; Fukuda H;
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):684-90. PubMed ID: 20932658
[TBL] [Abstract][Full Text] [Related]
7. Cardiac volume reduction during radiotherapy in patients with esophageal carcinoma.
Makita K; Hamamoto Y; Kanzaki H; Makita A; Nagasaki K
Mol Clin Oncol; 2024 Mar; 20(3):19. PubMed ID: 38332993
[TBL] [Abstract][Full Text] [Related]
8. The potential overdose of heart and left anterior descending coronary artery region during intensity-modulated radiation therapy in patients with esophageal cancer.
Makita K; Hamamoto Y; Kanzaki H; Nagasaki K
J Radiat Res; 2024 Mar; 65(2):238-243. PubMed ID: 38151920
[TBL] [Abstract][Full Text] [Related]
9. Novel Photodynamic Therapy for Esophageal Squamous Cell Carcinoma following Radiotherapy.
Yanagita T; Hikichi T; Nakamura J; Hashimoto M; Kato T; Suzuki R; Sugimoto M; Sato Y; Irie H; Takagi T; Kobayakawa M; Ohira H
Life (Basel); 2023 May; 13(6):. PubMed ID: 37374059
[TBL] [Abstract][Full Text] [Related]
10. Endoscopic findings suggestive of a high risk of non-radical cure after definitive chemoradiotherapy for cT1bN0M0 esophageal squamous cell carcinoma.
Fukuhara M; Urabe Y; Oka S; Ishibashi K; Konishi H; Mizuno J; Tanaka H; Tsuboi A; Yamashita K; Hiyama Y; Takigawa H; Kotachi T; Yuge R; Hayashi R; Nishibuchi I; Murakami Y; Nagata Y; Tanaka S
Esophagus; 2023 Jul; 20(3):541-547. PubMed ID: 37027046
[TBL] [Abstract][Full Text] [Related]
11. Esophageal cancer practice guidelines 2022 edited by the Japan esophageal society: part 1.
Kitagawa Y; Ishihara R; Ishikawa H; Ito Y; Oyama T; Oyama T; Kato K; Kato H; Kawakubo H; Kawachi H; Kuribayashi S; Kono K; Kojima T; Takeuchi H; Tsushima T; Toh Y; Nemoto K; Booka E; Makino T; Matsuda S; Matsubara H; Mano M; Minashi K; Miyazaki T; Muto M; Yamaji T; Yamatsuji T; Yoshida M
Esophagus; 2023 Jul; 20(3):343-372. PubMed ID: 36933136
[No Abstract] [Full Text] [Related]
12. Long‑term prognosis and comprehensive endoscopic treatment strategy for esophageal cancer, including salvage endoscopic treatment after chemoradiation therapy.
Shiota J; Yamaguchi N; Isomoto H; Taniguchi Y; Matsushima K; Akazawa Y; Nakao K
Exp Ther Med; 2023 Mar; 25(3):121. PubMed ID: 36815973
[TBL] [Abstract][Full Text] [Related]
13. Assessment of photodynamic therapy as a salvage treatment for local failure after chemoradiotherapy or radiotherapy for esophageal cancer in patients aged 80 years or older.
Nishikawa M; Yamamoto Y; Kushida S; Hirabayashi T; Tanaka S; Takegawa N; Mimura T; Tsumura H; Miki I; Tsuda M
DEN Open; 2023 Apr; 3(1):e167. PubMed ID: 36189170
[TBL] [Abstract][Full Text] [Related]
14. Long-Term Treatment Outcomes of the Elder Patients with Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma with Definitive Chemoradiotherapy or Radiotherapy.
Liu J; Li Y; Chen Y; Jiang X; Yu H; Yan S
Contrast Media Mol Imaging; 2022; 2022():3678441. PubMed ID: 35924070
[TBL] [Abstract][Full Text] [Related]
15. Association between unintentional splenic radiation and lymphopenia and high neutrophil/lymphocyte ratio after radiotherapy in patients with esophageal cancer.
Sakaguchi M; Maebayashi T; Aizawa T; Ishibashi N; Okada M
Transl Cancer Res; 2021 Dec; 10(12):5076-5084. PubMed ID: 35116359
[TBL] [Abstract][Full Text] [Related]
16. Management of Locally Advanced Esophageal Cancer.
Thakur B; Devkota M; Chaudhary M
JNMA J Nepal Med Assoc; 2021 Apr; 59(236):409-416. PubMed ID: 34508544
[TBL] [Abstract][Full Text] [Related]
17. Repeated talaporfin sodium photodynamic therapy for esophageal cancer: safety and efficacy.
Tamaoki M; Yokoyama A; Horimatsu T; Hirohashi K; Amanuma Y; Higuchi H; Mitani Y; Yoshioka M; Ohashi S; Muto M
Esophagus; 2021 Oct; 18(4):817-824. PubMed ID: 34106353
[TBL] [Abstract][Full Text] [Related]
18. Establishment and Verification of a Prediction Model for Symptomatic Radiation Pneumonitis in Patients with Esophageal Cancer Receiving Radiotherapy.
Yang LT; Zhou L; Chen L; Liang SX; Huang JQ; Zhu XD
Med Sci Monit; 2021 May; 27():e930515. PubMed ID: 33953150
[TBL] [Abstract][Full Text] [Related]
19. Past, present, and future of three-field lymphadenectomy for thoracic esophageal cancer.
Udagawa H
Ann Gastroenterol Surg; 2020 Jul; 4(4):324-330. PubMed ID: 32724875
[TBL] [Abstract][Full Text] [Related]
20. Definitive chemoradiotherapy for squamous cell carcinoma of the esophagus: outcomes for borderline-resectable disease.
Ishikura S; Kondo T; Murai T; Ozawa Y; Yanagi T; Sugie C; Miyakawa A; Shibamoto Y
J Radiat Res; 2020 May; 61(3):464-469. PubMed ID: 32249307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
